SEC FORM 3

SEC FORM 3SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Missulawin Jonathan

(Last)

(First)

(Middle)

C/O POLYPID LTD.

18 HASIVIM STREET ISRAEL

(Street)

PETACH TIKVA

495376

(City)

(State)

(Zip)

ISRAEL

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
PolyPid Ltd. [ PYPD ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Financial Officer

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Employee Stock option (right to buy)	04/01/2017	03/08/2027	Ordinary Shares	20⁽¹⁾	$123.01	D
Employee Stock option (right to buy)	02/02/2018	11/02/2027	Ordinary Shares	60⁽²⁾	$23.07	D
Employee Stock option (right to buy)	05/06/2020	02/06/2030	Ordinary Shares	16⁽³⁾	$23.07	D
Employee Stock option (right to buy)	06/11/2021	06/11/2030	Ordinary Shares	1,083⁽⁴⁾	$23.07	D
Employee Stock option (right to buy)	05/09/2023	05/09/2032	Ordinary Shares	1,167⁽⁵⁾	$23.07	D
Employee Stock option (right to buy)	08/09/2022	08/09/2031	Ordinary Shares	667⁽⁶⁾	$23.07	D
Employee Stock option (right to buy)	08/07/2024	08/07/2033	Ordinary Shares	10,000⁽⁷⁾	$11.01	D
Employee Stock option (right to buy)	08/06/2024	05/06/2034	Ordinary Shares	64,500⁽⁸⁾	$4.64	D
Employee Stock option (right to buy)	06/09/2025	05/06/2034	Ordinary Shares	43,000⁽⁹⁾	$4.64	D
Employee Stock option (right to buy)	08/12/2025	05/12/2035	Ordinary Shares	42,000⁽¹⁰⁾	$2.67	D
Employee Stock option (right to buy)	06/09/2025	05/12/2035	Ordinary Shares	28,000⁽¹¹⁾	$2.67	D

Explanation of Responses:

1. The options were granted on March 8, 2017 and fully vested as of March 8, 2020.

2. The options were granted on November 2, 2017 and fully vested as of November 2, 2020.

3. The options were granted on February 6, 2020 and fully vested as of February 6, 2023.

4. The options were granted on June 11, 2020 and vest on a quarterly basis beginning September 11, 2021 until June 11, 2024.

5. The options were granted on May 9, 2022 and vest on a quarterly basis beginning August 9, 2023 until May 9, 2026.

6. The options were granted on August 9, 2021 and vest on a quarterly basis beginning November 9, 2022 until August 9, 2025.

7. The options were granted on August 7, 2023 and vest on a quarterly basis beginning November 7, 2024 until August 7, 2027.

8. The options were granted on May 6, 2024 and vest on a quarterly basis until May 6, 2028.

9. The options were granted on May 6, 2024 and vest on a quarterly basis until May 6, 2026.

10. The options were granted on May 12, 2025 and vest on a quarterly basis until May 12, 2029.

11. The options were granted on May 12, 2025 and vest on a quarterly basis until May 12, 2027.

	/s/ Jonathan Missulawin	03/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)